Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system

World Journal of Urology

Volumn 31, Issue 4, 2013, Pages 755-760

  Shoskes, Daniel A ^a   Nickel, J Curtis ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Multimodal therapy; Pelvic pain; Phenotype; Prostatitis

Indexed keywords

ALGORITHM; CLASSIFICATION; HUMAN; MALE; MYALGIA; PATHOPHYSIOLOGY; PHENOTYPE; PROSTATE; PROSTATITIS; PSYCHOLOGY; REVIEW; TREATMENT OUTCOME; URINARY TRACT;

ALGORITHMS; HUMANS; MALE; MYALGIA; PHENOTYPE; PROSTATE; PROSTATITIS; PSYCHOLOGY; TREATMENT OUTCOME; URINARY TRACT;

EID: 84881041222     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1075-6     Document Type: Review

References (30)

1. Shoskes DA (2008) Chronic prostatitis/chronic pelvic pain syndrome. Humana Press.
2. Persson BE, Ronquist G (1996) Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. J Urol 155: 958.
3. He L, Wang Y, Long Z, Jiang C (2010) Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis. Urology 75: 654.
4. Westesson KE, Shoskes DA (2010) Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat? Curr Urol Rep 11: 261.
5. Pontari MA, McNaughton-Collins M, O'leary MP, Calhoun EA, Jang T, Kusek JW, Landis JR, Knauss J, Litwin MS (2005) A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 96: 559.
6. Tripp DA, Nickel JC, Wang Y, Litwin MS, McNaughton-Collins M, Landis JR, Alexander RB, Schaeffer AJ, O'Leary MP, Pontari MA, Fowler JEJ, Nyberg LM, Kusek JW (2006) Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 7: 697.
7. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN (2003) Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 169: 592.
8. Nickel JC, Elhilali M, Emberton M, Vallancien G (2006) The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 97: 1242.
9. Nickel JC, O'Leary MP, Lepor H, Caramelli KE, Thomas H, Hill LA, Hoel GE (2011) Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 186: 125.
10. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JEJ, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LMJ, Litwin MS (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141: 581.
11. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, Litwin MS, Alexander RB, White PC, Berger R, Nadler R, O'Leary M, Liong ML, Zeitlin S, Chuai S, Landis JR, Kusek JW, Nyberg LM, Schaeffer AJ (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359: 2663.
12. Shoskes DA (2001) Use of antibiotics in chronic prostatitis syndromes. Can J Urol 8(Suppl 1): 24.
13. Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J (2003) Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62: 614.
14. Zhao WP, Zhang ZG, Li XD, Yu D, Rui XF, Li GH, Ding GQ (2009) Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Braz J Med Biol Res 42: 963.
15. Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DEJ, Sant GR (2005) Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 173: 1252.
16. Goldmeier D, Madden P, McKenna M, Tamm N (2005) Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 16: 196.
17. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54: 960.
18. Elist J (2006) Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 67: 60.
19. Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brahler E, Weidner W (2009) A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56: 544.
20. Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O'Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, Kusek JW, Nyberg LMJ, Schaeffer AJ (2010) Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 170: 1586.
21. Anderson RU, Wise D, Sawyer T, Glowe P, Orenberg EK (2011) 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol 185: 1294.
22. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM (2009) Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 182: 570.
23. Shoskes DA, Nickel JC, Rackley RR, Pontari MA (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 12: 177.
24. Shoskes DA, Nickel JC, Dolinga R, Prots D (2009) Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73: 538.
25. Samplaski MK, Li J, Shoskes DA (2012) Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 188: 1788.
26. Hedelin HH (2009) Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome. Scand J Urol Nephrol 43: 373.
27. Magri V, Wagenlehner F, Perletti G, Schneider S, Marras E, Naber KG, Weidner W (2010) Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. J Urol 184: 2339.
28. Davis SN, Binik YM, Amsel R, Carrier S (2013) Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes. J Urol 189: 146.
29. Samplaski MK, Li J, Shoskes DA (2011) Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 78: 653.
30. Shoskes DA, Nickel JC, Kattan MW (2010) Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75: 1249.